Paloma Partners Management CO X Biotech Inc. Transaction History

Paloma Partners Management CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$10.39 - $16.07 $254,513 - $393,650	-24,496 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$8.89 - $24.94 $217,769 - $610,930	24,496 New	24,496 $260,000
Q4 2018 Feb 14, 2019	SELL	$3.22 - $6.27 $34,586 - $67,346	-10,741 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$2.31 - $4.69 $180,836 - $367,151	-78,284 Reduced 87.93%	10,741 $34,000
Q2 2018 Aug 14, 2018	BUY	$4.04 - $5.13 $297,554 - $377,834	73,652 Added 479.1%	89,025 $399,000
Q1 2018 May 15, 2018	SELL	$3.92 - $5.35 $94,068 - $128,383	-23,997 Reduced 60.95%	15,373 $82,000
Q4 2017 Feb 14, 2018	BUY	$3.9 - $4.66 $153,543 - $183,464	39,370	39,370 $155,000

4.87M

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $203M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.